Concentra Group Holdings Parent, Inc. (CON)
NYSE: CON · Real-Time Price · USD
42.55
-0.44 (-1.02%)
At close: Nov 13, 2026, 4:00 PM EST
42.52
-0.03 (-0.07%)
Pre-market: Nov 16, 2026, 8:23 AM EST

Company Description

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.

The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business.

It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services.

It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces.

In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards.

The company was founded in 1979 and is based in Addison, Texas.

Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent logo
CountryUnited States
Founded1979
IPO DateJul 25, 2024
IndustryMedical Care Facilities
SectorHealthcare
Employees9,999
CEOMatthew DiCanio

Contact Details

Address:
5080 Spectrum Drive, Suite 1200W
Addison, Texas 75001
United States
Phone972 364 8000
Websiteconcentra.com

Stock Details

Ticker SymbolCON
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$23.50
CIK Code2014596
CUSIP Number20603L102
ISIN NumberUS20603L1026
Employer ID30-1006613
SIC Code8093

Key Executives

NamePosition
Matthew T. DiCanio M.B.A.President, Chief Executive Officer and Director
William Keith NewtonExecutive Chairman
John A. deLorimierExecutive Vice President and Chief Information and Technology Officer
Timothy F. RyanExecutive Vice President and Chief Legal Counsel
Dr. John R. Anderson DO, FACOEMExecutive Vice President and Chief Medical Officer
Tanner NewtonExecutive Vice President and Chief Financial Officer
Su Zan Nelson CPAExecutive Vice President and Chief Accounting Officer
Bill ChapmanVice President of Strategy and Investor Relations
Thomas A. DevasiaExecutive Vice President and Chief Marketing and Innovation Officer
Danielle KendallExecutive Vice President and Chief People Officer

Latest SEC Filings

DateTypeTitle
Nov 12, 2026144Filing
Nov 12, 2026144Filing
Nov 12, 2026144Filing
Nov 10, 2026SCHEDULE 13D/AFiling
Nov 10, 20268-KCurrent Report
Nov 9, 20268-KCurrent Report
Nov 5, 202610-QQuarterly Report
Nov 5, 20268-KCurrent Report
Sep 8, 20268-KCurrent Report
Sep 1, 2026SCHEDULE 13D/AFiling